Antigen Information
General Information of This Antigen
| Antigen ID | TAR0KQONX |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) |
|||||
| Gene Name | TNFRSF17 |
|||||
| Synonym | BCM; BCMA; B-cell maturation protein;CD_antigen=CD269 |
|||||
| Sequence |
MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILWTCL
GLSLIISLAVFVLMFLLRKINSEPLKDEFKNTGSGLLGMANIDLEKSRTGDEIILPRGLE YTVEECTCEDCIKSKPKVDSDHCFPLPAMEEGATILVTTKTNDYCKSLPAALSATEIEKS ISAR Click to Show/Hide
|
|||||
| Function |
Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
008 (BCMA)
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024222841A1 ADC62-4 |
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
[1] | |
wO2024222841A1 ADC62 |
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
OXDc-VA-PAB (PEG) |
[1] | |
wO2024222841A1 ADC64-4 |
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Undisclosed |
[1] | |
wO2024222841A1 ADC64 |
(S)B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Undisclosed |
[1] |
15B2GL
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
NZ761939B 15B2GL-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
Anti-BCMA antibody 15B2GL
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA 15B2GL-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA 15B2GL-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody 15B2WT
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA 15B2WT-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA 15B2WT-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody I09
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA I09-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA I09-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody J6M0
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA J6M0-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA J6M0-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody L15
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA L15-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA L15-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody M02
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA M02-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA M02-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody N22
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA N22-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA N22-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody P10
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA P10-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] | |
Anti-BCMA P10-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[3] |
Anti-BCMA antibody R347
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-BCMA R347-SG3249 |
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
CL2A |
[3] |
Anti-human BCMA IgG1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AMG 224 |
DM1 |
Microtubule (MT) |
4-[N-maleimidomethyl] cyclohexane-1-carboxylate (MCC) |
BCMA-A Anti-ody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
BCMA-A Antibody-Compound (X) |
BCMA-A Antibody-Compound (X) payload |
Undisclosed |
BCMA-A Antibody-Compound (X) linker |
[4] | |
BCMA-A Antibody-Compound (XI) |
BCMA-A Antibody-Compound (XI) payload |
Undisclosed |
BCMA-A Antibody-Compound (XI) linker |
[4] | |
BCMA-A Antibody-Compound (XIV) |
BCMA-A Antibody-Compound (XIV) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIV) linker |
[4] | |
BCMA-A Antibody-Compound (XVIII) |
BCMA-A Antibody-Compound (XVIII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XVIII) linker |
[4] | |
BCMA-A Antibody-Compound (Ie) |
BCMA-A Antibody-Compound (Ie) payload |
Undisclosed |
BCMA-A Antibody-Compound (Ie) linker |
[4] | |
BCMA-A Antibody-Compound (XIX) |
BCMA-A Antibody-Compound (XIX) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIX) linker |
[4] | |
BCMA-A Antibody-Compound (Ii) |
BCMA-A Antibody-Compound (Ii) payload |
Undisclosed |
BCMA-A Antibody-Compound (Ii) linker |
[4] | |
BCMA-A Antibody-Compound (XLI) |
BCMA-A Antibody-Compound (XLI) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLI) linker |
[4] | |
BCMA-A Antibody-Compound (XVI) |
BCMA-A Antibody-Compound (XIX) payload |
Undisclosed |
BCMA-A Antibody-Compound (XIX) linker |
[4] | |
BCMA-A Antibody-Compound (XL) |
BCMA-A Antibody-Compound (XL) payload |
Undisclosed |
BCMA-A Antibody-Compound (XL) linker |
[4] | |
BCMA-A Antibody-Compound (XLIII) |
BCMA-A Antibody-Compound (XLIII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLIII) linker |
[4] | |
BCMA-A Antibody-Compound (XLII) |
BCMA-A Antibody-Compound (XLII) payload |
Undisclosed |
BCMA-A Antibody-Compound (XLII) linker |
[4] | |
BCMA-A Antibody-Compound (XV) |
BCMA-A Antibody-Compound (XV) payload |
Undisclosed |
BCMA-A Antibody-Compound (XV) linker |
[4] |
BCMA-Ab1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MEDI2228 |
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
Belantamab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
αBCMA-MC-I034 |
Amine-I034 |
IKZF1/3 |
MC |
||
Belan-DVA-I030 |
I030 |
IKZF1/3 |
MC-DVA-PABC |
||
Belan-VA-I034 (4) |
I034 |
IKZF1/3 |
MC-VA |
||
Belan-VA-I034 (8) |
I034 |
IKZF1/3 |
MC-VA |
||
Belantamab mafodotin |
MMAF |
Microtubule (MT) |
Maleimido-caproyl |
[5] | |
Belantamab-Compound (Ia) |
NeoDegrader P1 |
Protein cereblon (CRBN) |
Belantamab-Compound (Ia) linker |
[6] | |
Belantamab-Compound (X) |
Belantamab-Compound (X) payload |
Undisclosed |
Belantamab-Compound (X) linker |
[4] | |
Belantamab-Compound (XI) |
Belantamab-Compound (XI) payload |
Undisclosed |
Belantamab-Compound (XI) linker |
[4] | |
Belantamab-Compound (XIV) |
Belantamab-Compound (XIV) payload |
Undisclosed |
Belantamab-Compound (XIV) linker |
[4] | |
Belantamab-Compound (XVIII) |
Belantamab-Compound (XVIII) payload |
Undisclosed |
Belantamab-Compound (XVIII) linker |
[4] | |
Belantamab-Compound (Ie) |
Belantamab-Compound (Ie) payload |
Undisclosed |
Belantamab-Compound (Ie) linker |
[4] | |
Belantamab-Compound (XIX) |
Belantamab-Compound (XIX) payload |
Undisclosed |
Belantamab-Compound (XIX) linker |
[4] | |
Belantamab-Compound (Ii) |
Belantamab-Compound (Ii) payload |
Undisclosed |
Belantamab-Compound (Ii) linker |
[4] | |
Belantamab-Compound (XLI) |
Belantamab-Compound (XLI) payload |
Undisclosed |
Belantamab-Compound (XLI) linker |
[4] | |
Belantamab-Compound (XVI) |
Belantamab-Compound (XIX) payload |
Undisclosed |
Belantamab-Compound (XIX) linker |
[4] | |
Belantamab-Compound (XL) |
Belantamab-Compound (XL) payload |
Undisclosed |
Belantamab-Compound (XL) linker |
[4] | |
Belantamab-Compound (XLIII) |
Belantamab-Compound (XLIII) payload |
Undisclosed |
Belantamab-Compound (XLIII) linker |
[4] | |
Belantamab-Compound (XLII) |
Belantamab-Compound (XLII) payload |
Undisclosed |
Belantamab-Compound (XLII) linker |
[4] | |
Belantamab-Compound (XV) |
Belantamab-Compound (XV) payload |
Undisclosed |
Belantamab-Compound (XV) linker |
[4] | |
DB-1325 |
PDUP5 |
Undisclosed |
Undisclosed |
[7] | |
wO2024169913A1 ADC08-01-8 |
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Cit-PABC |
[8] | |
wO2024169913A1 ADC08-01-4 |
B19 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
Mc-Val-Cit-PABC |
[8] |
GENA-111
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
GENA-111-AF |
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
[9] |
Humanized anti-BCMA mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
DXC009 |
Undisclosed |
Microtubule (MT) |
Undisclosed |
I09
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
I09-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
Ispectamab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Ispectamab debotansine |
SC347 |
Microtubule (MT) |
Cys-12 ADC linker |
L15
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
L15-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
M02
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
M02-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
N22
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
N22-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
P10
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
P10-SG3249 |
SG3199 |
Undisclosed |
CL2A |
[2] |
Pamlectabart
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Pamlectabart tismanitin |
HDP 30.2115 |
RNA polymerase II |
Mal-Val-Ala-PAB |
SG1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SG1-Val-Cit-MMAF8 |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
SG2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SG2-Val-Cit-MMAF8 |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
SG3
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SG3-Val-Cit-MMAF8 |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
STI-1260
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LN474-63 |
Monomethyl auristatin E |
Microtubule (MT) |
CN118079014A-linker-1 |
[11] | |
LN474-64 |
Monomethyl auristatin E |
Microtubule (MT) |
CN118079014A-linker-3 |
[11] |
TNFRSF17 mAb1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
cN113549127A ADC-1 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-1-linker |
[12] | |
cN113549127A ADC-2 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-2-linker |
[12] | |
cN113549127A ADC-3 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-3-linker |
[12] | |
cN113549127A ADC-4 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-4-linker |
[12] | |
cN113549127A ADC-5 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-5-linker |
[12] | |
cN113549127A ADC-6 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-6-linker |
[12] | |
cN113549127A ADC-7 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-7-linker |
[12] | |
cN113549127A ADC-8 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-8-linker |
[12] | |
cN113549127A ADC-9 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-9-linker |
[12] | |
cN113549127A ADC-10 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-10-linker |
[12] | |
cN113549127A ADC-11 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-11-linker |
[12] | |
cN113549127A ADC-12 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-12-linker |
[12] | |
cN113549127A ADC-13 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-13-linker |
[12] | |
cN113549127A ADC-14 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-14-linker |
[12] | |
cN113549127A ADC-15 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-15-linker |
[12] | |
cN113549127A ADC-16 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-16-linker |
[12] | |
cN113549127A ADC-17 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-17-linker |
[12] | |
cN113549127A ADC-18 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-18-linker |
[12] | |
cN113549127A ADC-19 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-19-linker |
[12] | |
cN113549127A ADC-20 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-20-linker |
[12] | |
cN113549127A ADC-21 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-21-linker |
[12] | |
cN113549127A ADC-22 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-22-linker |
[12] | |
cN113549127A ADC-23 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-23-linker |
[12] | |
cN113549127A ADC-24 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-24-linker |
[12] | |
cN113549127A ADC-25 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-25-linker |
[12] | |
cN113549127A ADC-26 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-26-linker |
[12] | |
cN113549127A ADC-27 |
Undisclosed |
Undisclosed |
CN113549127A-ADC-27-linker |
[12] |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
JS115 |
Undisclosed |
Undisclosed |
Undisclosed |
[13] | |
HD-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[14] | |
Ispectamab tazide |
Undisclosed |
Undisclosed |
Undisclosed |
[15] | |
LMB-75 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
[16] | |
LMB-70 |
Pseudomonas exotoxin PE24 |
Eukaryotic elongation factor 2 kinase (EEF2K) |
Undisclosed |
[17] | |
BCMA-077 |
Duostatin 5.2 |
Microtubule (MT) |
Proprietary Concortis linker |
[18] | |
BCMA-024 |
Duostatin 5.2 |
Microtubule (MT) |
Proprietary Concortis linker |
[18] |
References
